Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 115283065 | 11528306 | 5 | F | 20160808 | 20150921 | 20160815 | PER | US-ACTELION PHARMACEUTICALS US, INC.-A-US2015-121031 | ACTELION | 63.00 | YR | A | F | Y | 0.00000 | 20160815 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 115283065 | 11528306 | 1 | PS | VENTAVIS | ILOPROST | 1 | Respiratory (inhalation) | 5 MCG, 5-6X/DAY | MA0259M,MA026TA,MA0284U,MA02DL0 | 21779 | 5 | UG | INHALATION VAPOUR, SOLUTION | ||||||
| 115283065 | 11528306 | 2 | C | LETAIRIS | AMBRISENTAN | 1 | U | 0 | |||||||||||
| 115283065 | 11528306 | 3 | C | ADCIRCA | TADALAFIL | 1 | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 115283065 | 11528306 | 1 | Pulmonary arterial hypertension |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 115283065 | 11528306 | Bronchitis | |
| 115283065 | 11528306 | Cough | |
| 115283065 | 11528306 | Foreign body | |
| 115283065 | 11528306 | Headache | |
| 115283065 | 11528306 | Nasal congestion |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 115283065 | 11528306 | 1 | 20100921 | 0 |